In the latest trading session, McKesson (MCK) closed at $586.08, marking a -1.1% move from the previous day. The stock's performance was behind the S&P 500's daily gain of 0.88%. Meanwhile, the Dow ...

McKesson (MCK) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

VSee Health, Inc. (Nasdaq: VSEE), a leader in comprehensive digital health services and customized telehealth workflow streams, announces contracts with several medical technology solution companies ...

McKesson MCK has started 2025 on a positive note, with the stock climbing 4% so far in January as investors remain optimistic ...

The global healthcare supply chain management market, valued at US$ 3.51 billion in 2023, is forecasted to grow at a robust ...

Healthcare distribution market is an essential segment of the global healthcare supply chain, facilitating the efficient and ...

Medical Gloves Market The healthcare landscape in 2025 is poised for a transformative shift, driven by innovation and collaboration. US ...

McKesson, which is headquartered in Irving, Texas, operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International.

Evercore ISI analyst Elizabeth Anderson CFA reiterated a Buy rating on McKesson (MCK – Research Report) yesterday and set a price target of ...

Community Clinic of Southwest Missouri recently received a $30,000 grant to help women who often get overlooked when it comes to breast cancer screenings. The grant is administered by the National ...

McKesson (MCK) closed the most recent trading day at $585.08, moving +0.57% from the previous trading session. The stock exceeded the S&P 500, which registered a gain of 0.16% for the day. Meanwhile, ...